Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASAH1 | Q13510 | 2/20 | 0.56 |
| ▸ | MGLL | Q99685 | 3/20 | 0.51 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.49 |
| ▸ | TUBB | P07437 | 2/20 | 0.49 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.49 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.49 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.49 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.49 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.49 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.49 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.49 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.49 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.49 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.49 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.49 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.49 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.49 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | BRD2 | P25440 | 1/20 | 0.37 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29375797 | 1.00 | ASAH1 (0.56) | ASAH1MGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL425013 | 0.82 | ASAH1 (0.52) | ASAH1MGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL13246518 | 0.77 | MGLL (0.56) | ASAH1MGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL13246475 | 0.77 | MGLL (0.62) | ASAH1MGLLKMT2AHPGDFAAH | |
| SCHEMBL916881 | 0.74 | MGLL (0.73) | ASAH1MGLLFAAH | |
| SCHEMBL12116960 | 0.73 | ASAH1 (0.50) | ASAH1MGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL13246506 | 0.73 | ASAH1 (0.62) | ASAH1MGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL13246559 | 0.73 | MGLL (0.74) | ASAH1MGLLFAAH | |
| SCHEMBL3231181 | 0.73 | MGLL (0.65) | ASAH1MGLLFAAH | |
| SCHEMBL1277493 | 0.73 | TUBB4A (0.44) | ASAH1MGLLTUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240360060-A1 | 6-HYDROXY-CANNABIDIOL-C4 | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2024-10-31 | — | — | US | claimed |
| US-20240254072-A1 | DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2024-08-01 | — | — | US | claimed |
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | claimed |
| EP-4337631-A1 | DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY | GW Research Limited (GB) | 2024-03-20 | — | — | EP | claimed |
| CN-116253743-B | (+) -Paeovaitol derivative, pharmaceutical composition thereof, preparation method and application thereof | 中国科学院昆明植物研究所 | 2024-02-06 | — | — | CN | claimed |
| CN-117295706-A | cannabidiol-C4 derivatives for the treatment of epilepsy | 吉伟研究有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-117242049-A | 6-hydroxy-cannabidiol-C4 | 吉伟研究有限公司 | 2023-12-15 | — | — | CN | claimed |
| EP-4286393-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | Daiichi Sankyo Company, Limited (JP) | 2023-12-06 | — | — | EP | claimed |
| CN-116867795-A | Novel method for producing antibody-immunostimulant conjugate | 第一三共株式会社 | 2023-10-10 | — | — | CN | claimed |
| CN-116253743-A | (+) -Paeovaitol derivative, pharmaceutical composition thereof, preparation method and application thereof | 中国科学院昆明植物研究所 | 2023-06-13 | — | — | CN | claimed |
| CN-109743878-B | Suspension and grinding method | 昭和电工材料株式会社 | 2021-07-06 | — | — | CN | claimed |
| CN-111205340-B | Preparation method of sucrose-6-acetate | 万华化学集团股份有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-111205340-A | Preparation method of sucrose-6-acetate | 万华化学集团股份有限公司 | 2020-05-29 | — | — | CN | claimed |
| CN-107406752-B | Polishing agent, stock solution for polishing agent, and polishing method | 日立化成株式会社 | 2020-05-08 | — | — | CN | claimed |
| US-10283373-B2 | CMP polishing liquid and polishing method | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2019-05-07 | — | — | US | claimed |
| US-9944827-B2 | CMP polishing solution and polishing method | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2018-04-17 | — | — | US | claimed |
| US-20110318929-A1 | CMP POLISHING SOLUTION AND POLISHING METHOD | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2011-12-29 | — | — | US | claimed |
| US-6176909-B1 | IN POLYMERIC BINDER | XEROX CORPORATION | 2001-01-23 | — | — | US | claimed |
| US-20260146199-A1 | METHOD FOR PROCESSING SEMICONDUCTOR SUBSTRATE, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND PROCESSING SOLUTION FOR SEMICONDUCTOR DEVICE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2026-05-28 | — | — | US | disclosed |
| US-6176909-B1 | IN POLYMERIC BINDER | XEROX CORPORATION | 2001-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | PAICS, COASY, CDS2 | ASAH1 1438/4885MGLL 2383/4885TUBB4A 4083/4885 |
| US-20240360060-A1 | 6-HYDROXY-CANNABIDIOL-C4 | CNR2, CNR1, HTR4 | ASAH1 360/4885MGLL 810/4885TUBB4A 1749/4885 |
| US-20260146199-A1 | METHOD FOR PROCESSING SEMICONDUCTOR SUBSTRATE, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND PROCESSING SOLUTION FOR SEMICONDUCTOR DEVICE | AS3MT, ASH1L, HMOX2 | ASAH1 4582/4885MGLL 2494/4885TUBB4A 3221/4885 |
| US-20240254072-A1 | DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY | CNR2, CNR1, CYP4A11 | ASAH1 494/4885MGLL 2419/4885TUBB4A 1441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.